IL-6

IL-6 분자 정보

영어 이름Interleukin-6시판 약물 수5
임상 약물 수22표적 별명CTL Differentiation Factor,Interleukin 6 (Interferon, Beta 2),HSF,B-cell stimulatory factor 2,Interferon beta-2,IL6,IFNB2,IL-6,Interleukin-6,Interleukin 6,Hybridoma Growth Factor,IFN-Beta-2,BSF-2,CDF,B-Cell Differentiation Factor,Interferon, Beta 2,Interleukin BSF-2,BSF2,HGF
최고 연구 개발 단계Approved
영어 이름Interleukin-6
표적 별명CTL Differentiation Factor,Interleukin 6 (Interferon, Beta 2),HSF,B-cell stimulatory factor 2,Interferon beta-2,IL6,IFNB2,IL-6,Interleukin-6,Interleukin 6,Hybridoma Growth Factor,IFN-Beta-2,BSF-2,CDF,B-Cell Differentiation Factor,Interferon, Beta 2,Interleukin BSF-2,BSF2,HGF
시판 약물 수5
임상 약물 수22
최고 연구 개발 단계Approved

IL-6 제품 목록

  • 속성

    Protein (10)Kits (6)

  • 제품 라이브러리

    온라인 (14)연구 중 (2)

  • Human (10)Mouse (4)Cynomolgus (2)

  • 태그

    Tag Free (4)His Tag (3)His Tag & Avi Tag (3)- (6)

  • 마커

    Unconjugated (6)Biotin-labeled (4)- (6)

IL-6분자 배경

Interleukin 6 (IL-6) is also known as HGF, BSF2,HSF, IFNB2 and IL-6, originally identified as a B cell differentiation factor, is a multifunctional cytokine that regulates immune responses, hematopoiesis, acute phase responses, and inflammatory reactions.It is secreted by T cells, macrophages , monocytes, fibroblasts,endothelial cells,et.al. to stimulate immune response to trauma, especially burns or other tissue damage leading to inflammation. Interleukin 6 has been shown to interact with interleukin-6 receptor and glycoprotein. IL-6 is relevant to many disease processes such as diabetes,atherosclerosis, depression,Alzheimer's Disease,systemic,lupus erythematosus,prostate cancer and rheumatoid arthritis. Advanced/metastatic cancer patients have higher levels of IL-6 in their blood.Hence there is an interest in developing anti-IL-6 agents as therapy against many of these diseases.

IL-6분자 별명

IL6,Interleukin-6,BSF2,HSF,IFNB2

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
EnsereptidePXL-01Phase 3 ClinicalPromore PharmaCicatrix; Post-surgical adhesions; Tissue Adhesions
상세
OlokizumabCDP-6038; Anti-IL6-UCBPhase 3 ClinicalUcbArthritis; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Crohn Disease; Lung Diseases, Interstitial
상세
Efprezimod alfaCD24-Fc; HAS-CD24; CD24-Fc-IgG; MK-7110; MK7110Phase 3 ClinicalOncoimmune IncCoronavirus Disease 2019 (COVID-19); Dyslipidemias; Graft vs Host Disease; Hematopoietic stem cell transplantation (HSCT); HIV Infections; Leukemia; Leukemia, Myeloid, Acute; Melanoma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Solid tumours
상세
ZiltivekimabEX-6018; MEDI-5117; WBP-216; COR-001; NN6018Phase 3 ClinicalMedimmune LlcAnemia; Arthritis, Rheumatoid; Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Heart Failure; Inflammation; Myocardial Infarction; Renal Insufficiency, Chronic
상세
ClazakizumabBMS-645429; ALD518-003; ALD-518; CSL300; BMS-945429; CSL-300Phase 3 ClinicalAlder BiopharmaceuticalsArthritis, Psoriatic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; Cachexia; Carcinoma, Non-Small-Cell Lung; Cardiovascular Diseases; Cardiovascular Infections; Coronavirus Disease 2019 (COVID-19); Crohn Disease; Diabetes Mellitus; Fatigue; Frailty; Graft vs Host Disease; Inflammation; Kidney Failure, Chronic; Myocardial Infarction; Rejection of organ transplantation; Stomatitis
상세
Tabirafusp tedromerKSI-501ABC; KSI-501Phase 3 ClinicalKodiak Sciences IncDiabetic macular oedema; Retinal Diseases; Uveitis; Wet Macular Degeneration
상세
Tabirafusp alfaKSI-101; KSI-501PPhase 3 ClinicalKodiak Sciences IncMacular Edema
상세
BezisterimHE-3286; NE-3107Phase 3 ClinicalHarbor Therapeutics IncAlzheimer Disease; Arthritis, Rheumatoid; Brain Injuries, Traumatic; Colitis, Ulcerative; Diabetes Mellitus, Type 2; Insulin Resistance; Parkinson Disease; Post-Acute COVID-19 Syndrome
상세
VamikibartRO-7200220; RG-6179; EBI-031Phase 3 ClinicalSesen Bio IncDiabetic macular oedema; Macular Edema
상세
Sodium HypochloritePhase 3 ClinicalCystic Fibrosis; Dental Pulp Necrosis; Fibrosis; Infections; Pain; Pain, Postoperative; Pulpitis
상세
PacibekitugPF-04236921; TOUR006; TOUR-006; PF-4236921Phase 2 ClinicalPfizer IncArthritis, Rheumatoid; Cardiovascular Diseases; Crohn Disease; Graves Ophthalmopathy; Lupus Erythematosus, Systemic; Renal Insufficiency, Chronic
상세
SirukumabBA-003; CNTO-136Phase 2 ClinicalGlaxosmithkline Plc, Johnson & Johnson Innovative MedicineArthritis, Rheumatoid; Asthma; Coronavirus Disease 2019 (COVID-19); Depressive Disorder, Major; Giant Cell Arteritis; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Nephritis; Polymyalgia Rheumatica
상세
Anti-interleukin-6 receptor monoclonal antibody (Biocad)Phase 2 ClinicalBIOCAD JSCAutoimmune Diseases
상세
IsomyosamineMYMD-1Phase 2 ClinicalMymd Pharmaceuticals IncAnxiety; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Depression; Frailty; Hashimoto Disease; Healthy Aging; Inflammation; Sarcopenia
상세
FB-704AFB-704; FB-704APhase 2 ClinicalFountain Biopharma IncArthritis, Rheumatoid; Asthma
상세
GerilimzumabGB-224; RYI-008; ARGX-109Phase 1 ClinicalArgenx SeArthritis, Rheumatoid
상세
Tocilizumab biosimilar (Gedeon Richter/Mochida Pharmaceutical)Phase 1 ClinicalMycenax Biotech IncArthritis, Rheumatoid
상세
GFS-202-AGFS-202-A; GFS202APhase 1 ClinicalGenfleet Therapeutics (Shanghai) Co LtdCachexia
상세
SCD-153SCD-153Phase 1 ClinicalInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Johns Hopkins University, Sun Pharma Advanced Research Company LtdAlopecia Areata
상세
NEX-20ANEX-20APhase 1 ClinicalNanexa ABMultiple Myeloma
상세
LuxeptinibCG026806; CG-806; CG’806; CG-026806Phase 1 ClinicalCrystalgenomics IncHematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes
상세
WogoninChina Pharmaceutical University, Daewoong Pharmaceutical Co Ltd, Hefei Cosource Medicine Technology, Shandong Buchang Pharmaceuticals Co Ltd
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Luminol sodiumMP-1032ApprovedMetrio, SelvimPsoriasis; Immune System Diseasesnull1997-01-01Coronavirus Disease 2019 (COVID-19); Immune System Diseases; Plaque psoriasis; Psoriasis
상세
PomalidomideIMID-4047; CDC-394; CC-4047; IMiD-1ApprovedCelgene CorpImnovid, Actimid, Pomalyst/Imnovid, 安跃, PomalystUnited StatesMultiple MyelomaBristol-Myers Squibb Company2013-02-08Anemia, Sickle Cell; Atypical Squamous Cells of the Cervix; Bone Marrow Neoplasms; Carcinoma, Small Cell; Central Nervous System Neoplasms; Glioma; Graft vs Host Disease; Hodgkin Disease; Immunoglobulin Light-chain Amyloidosis; Lung Diseases, Interstitial; Lymphoma, Non-Hodgkin; Medulloblastoma; Multiple Myeloma; Myeloproliferative Disorders; Neurofibromatosis 1; Optic Nerve Glioma; Pancreatic Neoplasms; Plasmacytoma; Polycythemia Vera; Primary Myelofibrosis; Prostatic Neoplasms; Pulmonary Fibrosis; Renal Insufficiency; Sarcoma; Sarcoma, Kaposi; Scleroderma, Systemic; Solid tumours; Thrombocytosis; Waldenstrom Macroglobulinemia
상세
SiltuximabcCLB-8; CNTO-328ApprovedJohnson & JohnsonSylvantUnited StatesMulticentric Castleman's Disease (MCD)Recordati Rare Diseases Inc2014-04-23Bone Marrow Neoplasms; Carcinoma, Renal Cell; Castleman Disease; Colorectal Neoplasms; Cytokine Release Syndrome; Diabetes Mellitus, Type 1; Head and Neck Neoplasms; Immunoglobulin Light-chain Amyloidosis; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Lymphoma, Non-Hodgkin; Monoclonal Gammopathy of Undetermined Significance; Multicentric Castleman's Disease (MCD); Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms, Plasma Cell; Ovarian Neoplasms; Pancreatic Neoplasms; Pneumonia; Polycythemia Vera; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Prostatic Neoplasms; Psychotic Disorders; Rejection of lung transplantation; Respiratory Distress Syndrome, Adult; Respiratory Tract Diseases; Respiratory Tract Infections; Schizophrenia; Smoldering Multiple Myeloma; Thrombocytopenia
상세
Andrographolide/Sodium Hydrogen SulfiteApprovedBacterial Infections
상세
ThalidomideNSC-66847; NSC-527179; K-17; FPF-300; FPF300ApprovedCelgene CorpTalizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, ThaledMainland ChinaLeprosy, Lepromatous; Multiple MyelomaChangzhou Pharmaceutical Factory1982-01-01Acquired Immunodeficiency Syndrome; Adenocarcinoma, Clear Cell; Adenoma, Islet Cell; Amyotrophic Lateral Sclerosis; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Anemia, Sideroblastic; Angiodysplasia; Appendiceal Neoplasms; Arachnoiditis; Arteriovenous Malformations; Axial Spondyloarthritis; beta-Thalassemia; Burning Mouth Syndrome; Carcinoid Tumor; Carcinoma, Adenosquamous; Carcinoma, Hepatocellular; Cholangitis, Sclerosing; Colorectal Neoplasms; Cough; Endometrial Neoplasms; Endometriosis; Epilepsy; Erythema Nodosum; Gastric Antral Vascular Ectasia; Gastrointestinal Hemorrhage; Genetic Diseases, Inborn; Glioma; Graft vs Host Disease; Head and Neck Neoplasms; Hemoglobinopathies; HIV Infections; HIV Wasting Syndrome; Hodgkin Disease; Hormone-Resistant Prostate Neoplasms; Hypertension, Portal; Idiopathic Pulmonary Fibrosis; Kidney Neoplasms; Leiomyosarcoma; Leprosy, Lepromatous; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelomonocytic, Chronic; Liver Neoplasms; Lung Neoplasms
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호